No products in the cart.

Hero MCM-05 Cordyceps vs reishi
Home/ Compare/ Cordyceps vs Reishi

Cordyceps vs Reishi: Species, Nucleosides and What Trials Measured

Cordyceps is a category, not a species. It covers Ophiocordyceps sinensis, the wild caterpillar fungus the Chinese Pharmacopoeia standardises on adenosine, Cordyceps militaris, a cultivated species associated with cordycepin, and fermented mycelial strains such as Cs-4. Reishi, by contrast, is one species: Ganoderma lucidum, whose markers are beta-glucans and ganoderic acid triterpenoids.
The largest cordyceps trial enrolled 20 adults for 12 weeks. The one trial that gave both mushrooms together recorded no change in HbA1c.

Third Party Tested Batch Certificates Of Analysis Highest Quality Full Spectrum Global Shipping 100% Organic
Third Party Tested Batch Certificates Of Analysis Highest Quality Full Spectrum Global Shipping 100% Organic

At a glance

Property
Cordyceps
Reishi
Species
A category covering Ophiocordyceps sinensis and Cordyceps militaris.
A single species, Ganoderma lucidum, known as lingzhi.
Part used
Wild stroma with larva, cultivated fruiting body, or fermented mycelium.
The fruiting body, a bracket formed on hardwood.
Key measured compounds
The nucleosides cordycepin and adenosine, plus polysaccharides.
Beta-glucans and ganoderic acid triterpenoids, no notable nucleosides.
Beta-glucan content
Seldom declared; cordyceps is standardised on nucleosides instead.
47.5% to 55.9% of dry weight in fruiting bodies, by strain.
Extraction method needed
Hot water is enough; cordycepin and adenosine are water soluble.
Hot water and alcohol, since triterpenoids are not water soluble.
Traditional use context
Dong chong xia cao, a tonic in Chinese and Tibetan practice.
Lingzhi, named in Chinese materia medica for 2,000 years.
Human trials
20 adults on Cs-4 for 12 weeks; 28 on a militaris blend.
5 randomised cancer trials, 5 cardiovascular trials, 132 neurasthenia cases.
What the evidence does not show
No trial has set O. sinensis against C. militaris.
No human study has measured uptake of its triterpenoids.
Endoca product
Endoca Cordyceps Mushroom Extract, 30 organic vegan capsules, 1 daily.
Endoca Red Reishi Mushroom Extract, organic capsules, 1 daily.

What these two actually are

The difference starts with how many organisms each word covers. Reishi is one: Ganoderma lucidum, a bracket fungus of hardwood, and the part used is the fruiting body. Cordyceps covers several. Ophiocordyceps sinensis, until recently Cordyceps sinensis, is the wild caterpillar fungus collected as a stroma still joined to the mummified larva. Cordyceps militaris is a separate species raised indoors on grain or silkworm pupae.
Then there is Cs-4, which is neither of those. Cs-4 is a fermented mycelium published as Paecilomyces hepiali Chen, and it supplied most of the Chinese clinical work on cordyceps. The anamorph of O. sinensis is a different organism again, Hirsutella sinensis. A 2015 review of the Chinese cordyceps industry notes that the absence of a defined classification system confuses pharmaceutical scientists as well as shoppers.
The practical consequence is this. A jar labelled cordyceps may hold wild O. sinensis, a cultivated militaris fruiting body, Cs-4 mycelium, or mycelium grown on grain. Reishi varies by strain and substrate only. Cordyceps varies by species, by part and by process, and its marker compound moves with all three.

Beta-glucans, and why the number on the label may not mean what you think

MCM-05 Cordyceps vs reishisecond section

Reishi’s headline figure is beta-glucan, and it is arrived at as total glucan minus alpha-glucan. The subtraction is there because grain starch reads as alpha-glucan, so a crude polysaccharide figure inflates with substrate. Ganoderma lucidum fruiting bodies raised on five tree species returned 47.5 to 55.9 percent beta-glucan of dry weight on that assay.
Cordyceps does not use that figure. Its markers are nucleosides. The Chinese Pharmacopoeia standardises Ophiocordyceps sinensis on adenosine, while Cordyceps militaris is characterised by cordycepin, which is 3′-deoxyadenosine: adenosine with a single hydroxyl removed from the ribose. One hydroxyl group separates the two markers, and the species they identify are not the same.
In absolute terms neither fungus is nucleoside rich. An HPLC survey of six fungi recorded total nucleosides and nucleobases between 0.14 and 26.57 mg per g of dry matter, with Cordyceps sinensis, Cordyceps militaris and Ganoderma lucidum all below the three culinary species examined, and under 1 mg per g in the stipe and cap of G. lucidum. Spore-bearing tissue held far more than other parts of the same fungus, so part used moves the number again.

What the human evidence shows

Cordyceps
The material in that 12-week cordyceps trial was Cs-4 rather than a fruiting body; threshold rose from 0.83 to 0.93 L/min in 20 adults aged 50 to 75.
VO2 max did not shift in either arm of that trial, and the placebo group recorded no threshold change.
A Cordyceps militaris blend at 4 g daily showed no significant interaction for VO2 max, ventilatory threshold or time to exhaustion across 28 adults at 1 week.
In the same trial VO2 max rose after 3 weeks, but only in the 10 participants who continued, too small a group to carry weight.
Reishi
A Ganoderma lucidum polysaccharide extract at 1,800 mg three times daily for 8 weeks lowered Clinical Global Impression severity scores in 132 patients with neurasthenia.
Given to 84 adults with type 2 diabetes at 3 g daily over 16 weeks, alone or with Cordyceps sinensis, it shifted HbA1c by 0.13 percent, 95 percent CI minus 0.35 to 0.60.
A 2026 review recorded no Ganoderma lucidum nanoformulation reaching human study, naming weak systemic exposure of its triterpenoids and polysaccharides as the open problem.

Read the positives narrowly. A 20-person trial moved a submaximal threshold and left VO2 max alone. A 132-patient trial moved a clinician rating scale. The flat results are firmer: no HbA1c change at 16 weeks and no exercise change at 1 week.

What people get wrong

01 Cordyceps is one mushroom.
The word covers several organisms: Ophiocordyceps sinensis, Cordyceps militaris and Cs-4, a fermented mycelium published as Paecilomyces hepiali. Their marker compounds are not the same.
02 Cordycepin is in every cordyceps product.
Cordycepin is the marker tied to Cordyceps militaris. Ophiocordyceps sinensis is standardised on adenosine in the Chinese Pharmacopoeia. A declared cordycepin figure is a statement about which species is in the capsule.
03 Reishi and cordyceps do the same job.
Their chemistry diverges. Reishi is measured by beta-glucans and ganoderic acid triterpenoids, cordyceps by nucleosides. The single trial that gave both at once recorded no HbA1c change over 16 weeks.

Choosing between them

The two were measured against different endpoints, which is the practical way to choose between them. Cordyceps was tested in exercise physiology: one 12-week trial in 20 older adults, using Cs-4 rather than a fruiting body. Reishi was tested as an oncology adjunct and on symptom scales, in small trials that two Cochrane reviews rated poor. If cordyceps is the choice, ask which species and which process, because one label word covers four different materials. For reishi, the question to ask is whether the extraction used two solvents or one.

How Endoca tests for this

Endoca publishes a certificate of analysis per mushroom extract, backed by pesticide, heavy metal and mycotoxin screening to GMP standards and third party verification. The two figures a careful buyer would want are absent: no adenosine or cordycepin result for the cordyceps capsule, no beta-glucan or triterpene result for the reishi. Those are worth requesting rather than inferring from a species name. Endoca works from its own farm, own land and own extraction, since 2010.

Frequently asked questions

Usually Cordyceps militaris, cultivated indoors on grain or silkworm pupae, or a fermented mycelium such as Cs-4. Wild Ophiocordyceps sinensis is scarce. The three materials carry different marker compounds, so the species and the process are both worth asking about before buying.

By a single hydroxyl group. Cordycepin is 3′-deoxyadenosine, which is adenosine missing one hydroxyl on the ribose ring. Ophiocordyceps sinensis is standardised on adenosine in the Chinese Pharmacopoeia, while cordycepin is the marker tied to Cordyceps militaris, so each marker names a different species.

A fermented mycelial cordyceps material published as Paecilomyces hepiali Chen, and the preparation behind most Chinese clinical research on cordyceps. It is not a fruiting body. Cs-4 at 333 mg three times daily is what the 12-week trial in 20 older adults gave.

Once. An 84-participant trial randomised adults with type 2 diabetes and metabolic syndrome to Ganoderma lucidum, Ganoderma lucidum with Cordyceps sinensis, or placebo at 3 g a day for 16 weeks, and recorded no change in HbA1c or fasting plasma glucose.

References

01

Chen S, Li Z, Krochmal R, Abrazado M, Kim W, Cooper CB. Effect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy older subjects: a double-blind, placebo-controlled trial. J Altern Complement Med. 2010;16(5):585-590.

02

Hirsch KR, Smith-Ryan AE, Roelofs EJ, Trexler ET, Mock MG. Cordyceps militaris improves tolerance to high-intensity exercise after acute and chronic supplementation. J Diet Suppl. 2017;14(1):42-53.

03

Dong C, Guo S, Wang W, Liu X. Cordyceps industry in China. Mycology. 2015;6(2):121-129.

04

Yuan JP, Zhao SY, Wang JH, Kuang HC, Liu X. Distribution of nucleosides and nucleobases in edible fungi. J Agric Food Chem. 2008;56(3):809-815.

05

Klupp NL, Kiat H, Bensoussan A, Steiner GZ, Chang DH. A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome. Sci Rep. 2016;6:29540.

06

Tang W, Gao Y, Chen G, Gao H, Dai X, Ye J, Chan E, Huang M, Zhou S. A randomised, double-blind and placebo-controlled study of a Ganoderma lucidum polysaccharide extract in neurasthenia. J Med Food. 2005;8(1):53-58.

07

Klupp NL, Chang D, Hawke F, Kiat H, Cao H, Grant SJ, Bensoussan A. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Database Syst Rev. 2015;(2):CD007259.

08

Cortina-Escribano M, Pihlava JM, Miina J, Veteli P, Linnakoski R, Vanhanen H. Effect of strain, wood substrate and cold treatment on the yield and beta-glucan content of Ganoderma lucidum fruiting bodies. Molecules. 2020;25(20):4732.

09

Qu Y, Zhao X, Liu H, Ren R, Qu W, Wang S, Ma G. From remedy to therapy: confronting the bioavailability bottleneck in Ganoderma lucidum translational research. Pharmaceuticals (Basel). 2026;19(8):1171.

10

Ko YF, Liau JC, Lee CS, Chiu CY, Martel J, Lin CS, Tseng SF, Ojcius DM, Lu CC, Lai HC, Young JD. Isolation, culture and characterization of Hirsutella sinensis mycelium from caterpillar fungus fruiting body. PLoS One. 2017;12(1):e0168734.

11

Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods, Annex, beta-glucans entries, as it applies in Great Britain.

Last reviewed 1 October 2026.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.